INDIA
China
Pakistan
Nepal
Delhi
Bangladesh
India
Myanmar
Trends and Developments Contributed by: Vaibhav Choukse, Ela Bali, Nripi Jolly and Faiz Siddiqui JSA JSA is a leading full-service national firm with more than 650 professionals across eight offic - es. The competition team at JSA has been at the forefront since the inception of India’s competi - tion regime, advising on merger control, cartels (including leniency), abuse of dominance, com - pliance, and antitrust litigation. The team has secured CCI approvals for numerous complex
Sri Lanka
transactions, including ChemChina’s USD44 billion acquisition of Syngenta, Temasek’s ac - quisition of shareholding in Haldiram, VFS Global and Manipal Hospital, EQT’s acquisition of shareholding in Indira IVF and HDFC Credila, IBM’s global separation of its MIS Business into Kyndryl, and ONGPL’s acquisition of Ayana Re - newables.
Authors
Vaibhav Choukse is an equity partner at JSA with more than 15 years of experience, who has been practising competition law since its inception in India. He specialises in complex
Ela Bali is a partner at JSA’s competition law practice, with more than 10 years of experience. She advises clients on merger control, cartels, abuse of dominance, and
enforcement and merger control, advising on both Form I and II filings, and has worked with the government and the CCI on drafting the Combination Regulations and amendments to the Competition Act. Vaibhav is consistently ranked among India’s leading competition lawyers by Chambers and Partners, including in the Chambers Asia-Pacific 2025 Guide and the Chambers Global Guide 2025.
compliance. She has secured CCI approvals for complex deals, including ChemChina’s USD44 billion acquisition of Syngenta. Ela has been recognised by Chambers and Partners and is ranked in Competition/Antitrust in the Chambers Asia-Pacific Guide 2025 and the Chambers Global Guide 2025.
275 CHAMBERS.COM
Powered by FlippingBook